Adaptimmune Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.1k | 10k | 0.79 |
| 2023-09-30 | $8.1k | 10k | 0.78 |
| 2023-06-30 | $9.7k | 10k | 0.93 |
| 2023-03-31 | $12k | 11k | 1.09 |
| 2022-12-31 | $15k | 10k | 1.46 |
| 2022-09-30 | $11k | 11k | 1.04 |
| 2022-06-30 | $18k | 11k | 1.70 |
| 2022-03-31 | $22k | 11k | 2.08 |
| 2020-06-30 | $104k | 10k | 10.00 |
| 2020-03-31 | $57k | 21k | 2.74 |
| 2019-12-31 | $35k | 29k | 1.19 |
| 2019-09-30 | $39k | 26k | 1.51 |
| 2019-06-30 | $89k | 22k | 4.02 |
| 2019-03-31 | $130k | 30k | 4.31 |
| 2018-12-31 | $132k | 23k | 5.76 |
| 2018-09-30 | $195k | 14k | 13.53 |
| 2018-06-30 | $185k | 16k | 11.86 |
| 2018-03-31 | $282k | 25k | 11.22 |
| 2017-12-31 | $114k | 17k | 6.67 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates